Indivior's new antipsychotic wins FDA nod, but Suboxone patent fight could delay its launch

30th July 2018 Uncategorised 0

Just as Indivior stalls Dr. Reddy’s rollout of a generic to its top-selling drug, Suboxone Film, the launch of a newly minted drug of Indivior’s own might become collateral damage of the patent fight and the slow ramp-up of fellow newcomer Sublocade.

More: Indivior's new antipsychotic wins FDA nod, but Suboxone patent fight could delay its launch
Source: fierce